

 
 
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
 
Most Trending
-18.18%
-4.24%
+1.44%
-7.66%
SYK
Stryker
$368.98
 Login to see Stryker (SYK)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to see Stryker (SYK)  Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths

Upgraded on attractively valued

Trading below its fair value

Investors confidence is positive
Chart
$370.5 (-0.41%)
$376.37 (-1.96%)
$385.05 (-4.17%)
$383.28 (-3.73%)
SYK has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

 
SYK overall standing based on key factors, offering insights into analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value

SYK Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
SYK Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
 Login to display
  Login to displaySYK Earnings
The TTM reflects 12-month period, providing review of SYK financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
BSX
100.57
+0.26%
IART
11.81
-23.46%
TFX
124.84
-2.56%
PROF
6.12
-0.16%
PAVM
0.42
-3.49%
What is SYK current stock price?
What are SYK stock strengths?
What risks are associated with SYK stock?
When is SYK next earnings report?
What is SYK market cap and volume?
What is SYK's current Stock IQ?
Should I buy SYK stock right now?
Is SYK a Strong Buy right now?
What does a 'Strong Buy' rating mean for SYK?
What does a 'Strong Sell' rating mean for SYK?
What factors influence SYK's Stock IQ?
 
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-18.18%
-4.24%
+1.44%
-7.66%
SYK
Stryker
Current Price
$368.98
Stock Insights
Strengths

Upgraded on attractively valued

Trading below its fair value

Investors confidence is positive
Linked to SYK
BSX
100.57
+0.26%
IART
11.81
-23.46%
TFX
124.84
-2.56%
PROF
6.12
-0.16%
PAVM
0.42
-3.49%
 Login to unlock Stryker (SYK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
  Login to unlock Stryker (SYK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid  
Chart
$370.5 (-0.41%)
$376.37 (-1.96%)
$385.05 (-4.17%)
$383.28 (-3.73%)
SYK Analysts Opinion
 
SYK Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
 Hover over the category for more information
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Trading below its fair value

SYK Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
 
 
SYK Street view is extremely bullish and have positive views on the near-term outlook
SYK has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
 Login to display
  Login to displaySYK Earnings
The TTM data reflects the most recent 12-month period, providing overview of SYK financial performance.
SYK Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
SYK Latest Analysis
Stryker Corp. Q3 Profit Increases Beats Estimates . (RTTNews) - Stryker Corp. (SYK) revealed earnings for its third quarter that Increased from the same period last year and beat the Street estimates.
Thu Oct 30, 2025
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates. Stryker (SYK) delivered earnings and revenue surprises of 1.59% and 0.24% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Thu Oct 30, 2025
Stryker raises 2025 outlook to 9.8%-10.2% organic sales growth as momentum accelerates.
Thu Oct 30, 2025
Stryker down despite boosting 2025 outlook and Q3 beats.
Thu Oct 30, 2025
Will SYKs Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics?. Strykers Q3 results are expected to highlight MedSurg strength and solid robotics-led growth in Orthopaedics partly offset by tariff headwinds.
Fri Oct 24, 2025
Barclays Maintains Stryker (SYK) Overweight Recommendation. Fintel reports that on October 22 2025 Barclays maintained coverage of Stryker (NYSE:SYK) with a Overweight recommendation. Analyst Price Forecast Suggests 13.70% Upside
Thu Oct 23, 2025
Stryker Breaks Above 200-Day Moving Average - ish for SYK. In trading on Monday shares of Stryker Corp (Symbol: SYK) crossed above their 200 day moving average of $379.54 changing hands as high as $381.77 per share. Stryker Corp shares are currently trading up about 1.9% on the day. The chart below shows the one year performance of
Mon Oct 20, 2025
Zacks.com featured highlights include Stryker NVIDIA ResMed and Ralph Lauren. Zacks highlights four GARP (Growth at a Reasonable Price) stocks Stryker NVIDIA ResMed and Ralph Lauren combining strong growth prospects with attractive valuations for maximum returns.
Mon Oct 20, 2025
Truist Securities Maintains Stryker (SYK) Hold Recommendation. Fintel reports that on October 15 2025 Truist Securities maintained coverage of Stryker (NYSE:SYK) with a Hold recommendation. Analyst Price Forecast Suggests 19.40% Upside
Thu Oct 16, 2025
 
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS"). 
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.